Novavax raises doubts about its ability to remain in business
By Michael Erman NEW YORK (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced...
Stay updated with breaking news from Michael Ermanediting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Michael Erman NEW YORK (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced...
COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign.
NEW YORK, Sept 22 (Reuters) - The United States is significantly cutting back the number of Pfizer PFE.N/BioNTech 22UAy.DE Covid-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries.
Coronavirus vaccines tweaked to include the Omicron variant strain can improve protection when used as a booster, the European Medicines Agency and other global health regulators said.
(Corrects first name of CDC researcher in fourth paragraph)